Benzinga··Vandana SinghPfizer's Weight-Loss Drug Wins China Approval, Intensifying GLP-1 Competition
Pfizer wins NMPA approval for weight-loss drug ecnoglutide in China, achieving 15.4% average weight loss in trials, intensifying competition as Novo Nordisk's Wegovy faces patent expiry.
PFELLYNVOclinical trialweight-loss drug